Table 6 Marginal effects during pre-intervention, intervention, post-intervention adjusted by gender and age using GEE. Sao Paulo (Brazil), 2018
Health Outcomes | Characteristics | Dy/dx | 95%CI | P |
BMI | Pre | 0.003 | (0.001; 0.005) | <0.001 |
Int | 0.803 | (0.006; 0.154) | 0.033 | |
Post | -0.0006 | (-0.0008; -0.0004) | <0.001 | |
Gender (female) | -0.005 | (-0.034; 0.024) | 0.744 | |
Age | 0.0007 | (-2.855; 3.001) | 0.105 | |
Weight | Pre | 0.002 | (-0.01; -0.01) | 0.804 |
Int | -58.404 | (-69.9; -46.9) | <0.001 | |
Post | 0.086 | (0.06; -0.1) | <0.001 | |
Gender (female) | -4.286 | (-5.29; -3.27) | <0.001 | |
Age | -0.12 | (-0.15; -0.08) | <0.001 | |
Blood pressure | Pre | -0.002 | (-0.005; 0.001) | 0.167 |
Int | 0.522 | (-1.66; 2.71) | 0.640 | |
Post | -0.006 | (-0.01; -0.001) | 0.007 | |
Gender (female) | 0.221 | (-1.6; 2.04) | 0.812 | |
Age | 0.007 | (-0.04; 0.06) | 0.808 | |
Cholesterol | Pre | -0.03 | (-0.04; -0.01) | <0.001 |
Int | 6.047 | (-0.78; 12.87) | 0.083 | |
Post | 0.046 | (0.03; 0.06) | <0.001 | |
Gender (female) | 9.214 | (7.43; 10.98) | <0.001 | |
Age | 0.121 | (0.06; 0.17) | <0.001 | |
VLDL | Pre | 0.007 | (0.003; 0.01) | <0.001 |
Int | 1.784 | (0.14; 3.42) | 0.033 | |
Post | -0.014 | (-0.01; -0.01) | <0.001 | |
Gender (female) | -0.108 | (-0.75; 0.54) | 0.744 | |
Age | 0.016 | (-0.003; 0.03) | 0.105 | |
LDL | Pre | -0.017 | (-0.02; -0.006) | 0.002 |
Int | -1.776 | (-7.95; 4.39) | 0.573 | |
Post | 0.033 | (0.01; 0.04) | <0.001 | |
Gender (female) | 6.900 | (5.58; 8.21) | <0.001 | |
Age | -0.039 | (-0.07; -0.0001) | 0.049 | |
HDL | Pre | 0.022 | (0.01; 0.02) | <0.001 |
Int | -8.427 | (-10.16; -6.69) | <0.001 | |
Post | -0.005 | (-0.008; -0.0006) | 0.023 | |
Gender (female) | 1.125 | (0.14; 2.1) | 0.024 | |
Age | 0.092 | (0.06; 0.12) | <0.001 | |
Triglycerides | Pre | 0.051 | (0.04; 0.06) | <0.001 |
Int | -6.802 | (-11.98; -1.61) | 0.01 | |
Post | -0.111 | (-0.12; -0.09) | <0.001 | |
Gender (female) | 6.805 | (5.27; 8.33) | <0.001 | |
Age | 0.18 | (0.13; 0.22) | <0.001 | |
Insulin | Pre | 0.014 | (0.01; 0.01) | <0.001 |
Int | -7.207 | (-9.05; -5.35) | <0.001 | |
Post | -0.017 | (-0.02; 0.01) | <0.001 | |
Gender (female) | 0.207 | (-0.3; 0.71) | 0.427 | |
Age | -0.001 | (-0.01; 0.01) | 0.885 | |
Glucose-linked haemoglobin | Pre | 0.013 | (0.003; 0.02) | 0.007 |
Int | -3.227 | (-8.41; 1.96) | 0.223 | |
Post | -0.051 | (-0.06; 0.03) | <0.001 | |
Gender (female) | 4.468 | (2.96; 5.97) | <0.001 | |
Age | -0.011 | (-0.05; 0.03) | 0.643 | |
Fasting glucose | Pre | 0.019 | (0.006; 0.03) | 0.003 |
Int | 8.873 | (1.76; 15.98) | 0.014 | |
Post | -0.095 | (-0.11; -0.07) | <0.001 | |
Gender (female) | 6.721 | (5.37; 8.06) | <0.001 | |
Age | 0.119 | (0.07; 0.15) | <0.001 | |
Health Care Costs | Characteristics | Dy/dx | 95%CI | P |
Direct cost | Pre | 1.153 | (1.12; 1.17) | <0.001 |
Int | 1189.518 | (1179.29; 1199.74) | <0.001 | |
Post | -4.323 | (-4.35; -4.29) | <0.001 | |
Gender (female) | -100.838 | (-103.32; -98.34) | <0.001 | |
Age | 1.303 | (1.22; 1.38) | <0.001 |